IDEXX Laboratories Inc (IDXX)vsSotera Health Co (SHC)
IDXX
IDEXX Laboratories Inc
$575.72
+0.97%
HEALTHCARE · Cap: $45.53B
SHC
Sotera Health Co
$13.70
-0.98%
HEALTHCARE · Cap: $3.93B
Smart Verdict
WallStSmart Research — data-driven comparison
IDEXX Laboratories Inc generates 270% more annual revenue ($4.30B vs $1.16B). IDXX leads profitability with a 24.6% profit margin vs 6.7%. SHC appears more attractively valued with a PEG of 1.68. SHC earns a higher WallStSmart Score of 62/100 (C+).
IDXX
Buy61
out of 100
Grade: C+
SHC
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-40.2%
Fair Value
$462.85
Current Price
$575.72
$112.87 premium
Margin of Safety
-37.4%
Fair Value
$12.64
Current Price
$13.70
$1.06 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 66 in profit
Keeps 25 of every $100 in revenue as profit
Strong operational efficiency at 29.8%
Strong operational efficiency at 35.7%
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Trading at 28.6x book value
Expensive relative to growth rate
4.6% revenue growth
1.8% earnings growth
6.7% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : IDXX
The strongest argument for IDXX centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 24.6% and operating margin at 29.8%. Revenue growth of 14.3% demonstrates continued momentum.
Bull Case : SHC
The strongest argument for SHC centers on Operating Margin.
Bear Case : IDXX
The primary concerns for IDXX are PEG Ratio, P/E Ratio, Price/Book. A P/E of 43.7x leaves little room for execution misses.
Bear Case : SHC
The primary concerns for SHC are PEG Ratio, Revenue Growth, EPS Growth. A P/E of 51.2x leaves little room for execution misses. Debt-to-equity of 4.14 is elevated, increasing financial risk.
Key Dynamics to Monitor
IDXX profiles as a mature stock while SHC is a value play — different risk/reward profiles.
SHC carries more volatility with a beta of 1.88 — expect wider price swings.
IDXX is growing revenue faster at 14.3% — sustainability is the question.
IDXX generates stronger free cash flow (323M), providing more financial flexibility.
Bottom Line
SHC scores higher overall (62/100 vs 61/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
IDEXX Laboratories Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.
Sotera Health Co
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical, and food industries in the Americas, Europe, and Asia. The company is headquartered in Broadview Heights, Ohio.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?